Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Participate in webinars on financial planning topics led by experts. These sessions are designed to enhance your knowledge and help you make informed decisions.
17,885 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
A drone sector rally sparked a sharp move in a related stock, grabbing headlines and attention. This guide breaks dow...
As July begins, the crypto market today, july shows renewed strength. Bitcoin tops 60k while other assets catch a bid...
California’s new labeling rules eliminate 'sell by' labels, standardizing consumer guidance to reduce food waste and ...
A social media rental listing can look legitimate, but a rushed decision often leads to a costly mistake. This guide ...
As America reshapes its manufacturing landscape, rare earths play a pivotal role in magnets, EVs, and wind turbines. ...
A landmark IPO move on July 7 could rewrite how investors think about liquidity and index dynamics. This guide breaks...
Meta Platforms and CoreWeave reported sharply different Q1 2026 results, highlighting Meta’s cash-flow machine and Co...
Apple announces a record onshore manufacturing pact with Broadcom, locking in billions of US-made chips and expanding...
As Tesla fans cheer long-term robotaxi dreams, traders worry about delivery misses. A growing crowd is exploring inve...
The U.S. government is on a heavy borrowing pace in fiscal 2026, with monthly borrowing around $155 billion and inter...
Micron unveils a historic plan to expand memory fabrication in the United States, led by CEO Sanjay Mehrotra. The mov...